Skip to content

Acquisition and Clinical Image Evaluation of Fujifilm's High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images.

Acquisition and Clinical Image Evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07471750
Enrollment
18
Registered
2026-03-13
Start date
2026-03-30
Completion date
2026-06-01
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Routine Screening Mammography

Keywords

Screening Mammogram, Mammogram, Digital Breast Tomosynthesis (DBT)

Brief summary

Acquisition and clinical image evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) images.

Detailed description

This study is designed to acquire Fujifilm DBT HR mode images and following image acquisition, includes a Clinical Image Evaluation study to assess whether Fujifilm HR DBT images are of sufficiently acceptable quality for use in clinical mammography.

Interventions

DEVICEDBT HR mode image acquisition

Fujifilm DBT HR image acquisition.

Sponsors

Fujifilm Medical Systems USA, Inc.
Lead SponsorINDUSTRY
International HealthCare, LLC
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Asymptomatic women who received a final BI-RADS Assessment Category of 1 or 2 on their routine screening mammogram will be invited and consented to have images obtained using DBT HR mode, with either N-mode or H-mode dose. These images will then be reviewed by expert radiologists where they will judge if the images are of sufficiently acceptable overall clinical image quality for use in clinical mammography.

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Have the ability to understand the requirements of the study, to provide written informed consent, and to comply with the study protocol; * Have the ability to understand and provide written authorization for the use and disclosure of protected health information (PHI) per the Health Insurance Portability and Accountability Act (HIPAA) privacy ruling; * Be female; * Be at least 40 years of age; * Be asymptomatic; and * Have received a final BI-RADS Assessment Category of 1 or 2 (negative or benign findings) on her routine screening mammogram.

Exclusion criteria

* Has a breast implant; * Is pregnant or believes she may be pregnant; * Has delivered and expressed the intention to breast-feed or is currently breast-feeding; * Has significant existing breast trauma with the last one (1) year; * Has any breast symptoms (e.g., breast lump, pain, nipple discharge); * Has been diagnosed or treated for breast cancer within the last year; or * Is an inmate (see US Code of Federal Regulations 45 CFR 46.306).

Design outcomes

Primary

MeasureTime frameDescription
Image AcquisitionEach study participant will attend a single study visit (acquisition).To acquire appropriate and sufficient cases to support the Clinical Image Evaluation part of the study.
Clinical Image Evaluation - Image qualityEach reader's clinical image evaluations are anticipated to be completed in less than one (1) day.To determine if the DBT HR mode clinical images, when reviewed by expert radiologists, are judged to be of sufficiently acceptable overall clinical image quality for use in clinical mammography.

Secondary

MeasureTime frameDescription
Image Acquisition - Safety evaluationEach study participant will attend a single study visit (acquisition).To further evaluate the safety of DBT HR mode imaging by analyzing frequency and characteristics of any adverse events.
Clinical Image Evaluation - Pass ratingEach reader's clinical image evaluations are anticipated to be completed in less than one (1) day.To determine whether overall clinical image quality is acceptable, as assessed by expert mammographic radiologists. Study success requires all of the cases to receive a Pass rating.

Contacts

CONTACTNicole M. Calabrese, MS
nicolec@ihcresearch.com518-506-9840
PRINCIPAL_INVESTIGATORLaurie L. Fajardo, MD

University of Utah

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026